SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-008423
Filing Date
2019-05-13
Accepted
2019-05-13 16:07:10
Documents
88
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0319_immucellcorp.htm 10-Q 567994
2 CERTIFICATION f10q0319ex31_immucellcorp.htm EX-31 7601
3 CERTIFICATION f10q0319ex32_immucellcorp.htm EX-32 4376
  Complete submission text file 0001213900-19-008423.txt   4428737

Data Files

Seq Description Document Type Size
4 XBRL PRESENTATION FILE iccc-20190331_pre.xml EX-101.PRE 321018
5 XBRL LABEL FILE iccc-20190331_lab.xml EX-101.LAB 408858
6 XBRL DEFINITION FILE iccc-20190331_def.xml EX-101.DEF 188975
7 XBRL SCHEMA FILE iccc-20190331.xsd EX-101.SCH 55971
8 XBRL CALCULATION FILE iccc-20190331_cal.xml EX-101.CAL 64811
9 XBRL INSTANCE FILE iccc-20190331.xml EX-101.INS 783927
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 19818436
SIC: 2835 In Vitro & In Vivo Diagnostic Substances